The independent source for health policy research, polling, and news.
621 - 640 of 995 Results
Clear differences of opinion emerged between Democrats and Republicans during a House Ways and Means subcommittee hearing about how to make prescription drugs more affordable in the Medicare program.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
KHN correspondent Emmarie Huetteman appeared on the C-SPAN program 鈥淲ashington Journal,鈥 where she fielded viewers鈥 calls about high drug prices and industry criticism.
Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Jennifer Haberkorn of the Los Angeles Times join KHN鈥檚 Julie Rovner to discuss the new 鈥淢edicare-for-all鈥 bill introduced by House Democrats, the grilling of pharmaceutical company CEOs by a Senate committee and new Trump administration rules that take aim at Planned Parenthood. Plus, Rovner interviews KHN鈥檚 Julie Appleby about the latest 鈥淏ill of the Month鈥 installment.
The progressive proposal adds details to the discussion of this controversial approach to overhauling the nation鈥檚 health system, and Democratic primary candidates will have to be prepared to get more specific.
Health and safety problems at immigration detention facilities throughout California pose a serious risk to detainees, according to two reports released Tuesday. State Attorney General Xavier Becerra and California State Auditor Elaine Howle concluded that federal and local governments are failing to adequately oversee the facilities, allowing the problems to persist.
The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.
Tuesday鈥檚 Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.
Most hearings before the U.S. House and Senate are routine affairs. But a few tense moments featuring everyone from Hillary Clinton to tobacco CEOs drew the attention of millions of Americans.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
Tuesday鈥檚 Senate hearing with pharma CEOs will tackle the same issues as the famous Kefauver hearings in 1960.
Confrontational hearings 60 years ago sparked remarkably similar quotes about drug prices and health care policy.
Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Anna Edney of Bloomberg News join KHN鈥檚 Julie Rovner to discuss the latest national health spending estimates, another FDA crackdown on dietary supplements and lawsuits between insurers and the federal government that could result in a windfall for consumers.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
The 鈥淢edicare鈥揻or-all鈥 debate is already in full swing, but what does that phrase even mean? Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN鈥檚 Julie Rovner for a beginner鈥檚 guide to the next big health policy debate. For 鈥渆xtra credit,鈥 the panelists provide their favorite health policy stories of the week, and as a special Valentine鈥檚 Day bonus, their favorite #HealthPolicyValentines.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
President Donald Trump wants Congress to allot $500 million over 10 years for pediatric cancer research. While it鈥檚 welcomed by researchers and advocates, it鈥檚 not a lot of money.
The Michigan Democrat chaired the House Energy and Commerce Committee and his impact on health care was immense.
The president鈥檚 promise to eliminate HIV transmission within 10 years is a goal long sought by advocates, but it won鈥檛 be an easy undertaking.
The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.
漏 2026 KFF